Company file

keyboard_backspaceBack to directory

Identity

CTIBiotech

Company specializing in dermatocosmetics and oncology research, in particular through 3D bioprinting of complex models and in-house testing. Bio-bank accredited to the Ministry of Education and Research, with more than 50,000 samples in stock and a network of 200 partners.

Cell-based bioassays to test the efficacy and the toxicity of products / ingredients. Key-in-hand, co-development. Ex vivo models (skin, scalp, sebaceous gland), in vitro (hair, sebocytes), bio-printed (skins). Bio-impression & tissue engineering, cell-culture, analysis (histology, fluorescence microscopy, flow cytometry...)

Contact

Bat A16, 5 avenue Lionel Terray
69330 Meyzieu
France

https://www.ctibiotech.com

romain.boisseau@ctibiotech.com

+33757440487

Activities

    Categories

    • Service company
    • Research structure

    Expertise

    CAR-T Cell
    • Analytical Process, Quality assement, Quality Control
    • Sterility
    • Safety for gene-edited cells : cytokine-independent growth
    • Targer Identification
    • Targer Identification
    • Biomarker Identificaton
    • Biomarker Identificaton
    • Adoptive T cell Major Challenges in Solid Tumors
    • Tumor/Ag heterogeneity
    • Tumor associated Antigen
    • Miroenvironment
    • Delivery/homing
    • Combinations
    • Bioproduction
    • Bioproduction
    • Scale-Up
    • Automate manufacturing
    • Automated high-throughput microbioreactor system
    • Supply chain logistics
    • Tracking process
    • Monitoring logistics
    • Ex Vivo & In Vivo Strategy
    • Ex Vivo & In Vivo Strategy
    • Cell acquisition
    • Allogenic
    • Cell Bank
    • Tissue acquisition
    • Apheresis
    • Target cell isolation
    • Differentiated Cell
    • Production Cell
    • Safety donor-derived therapies
    • Cell Expansion
    • Cell factory
    • Purification / extraction
    • Purification / extraction
    • Conditionning
    • Conditionning
    • Transport
    • Transport
    Cell Therapy / Engineering
    • Bioproduction
    • Bioproduction
    • Ex Vivo & In Vivo Strategy
    • Ex Vivo & In Vivo Strategy
    • Cell acquisition
    • Cell Bank
    • Tissue acquisition
    • Target cell isolation
    • Differentiated Cell
    • Production Cell
    • Safety donor-derived therapies
    • Cell Expansion
    • Cell factory
    • Purification / extraction
    • Purification / extraction
    • Conditionning
    • Conditionning
    • Transport
    • Transport
Français English